首页|期刊导航|Fundamental Research|Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity
Fundamental Research2025,Vol.5Issue(3):P.1298-1312,15.DOI:10.1016/j.fmre.2023.05.013
Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity
摘要
关键词
Liver cancer/Nanoparticle/Drug delivery/Chemoimmunotherapy/Combination therapy分类
医药卫生引用本文复制引用
Zhuo Yu,Yifang Zou,Shulan Han,Dandan Sun,Lingzhi Wang,Leilei Yang,Yutong Li,Xuemei Zhang,Jianfeng Guo..Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity[J].Fundamental Research,2025,5(3):P.1298-1312,15.基金项目
supported by National Natural Science Foundation of China(82222074,82074154 and 81774240) (82222074,82074154 and 81774240)
the Siming Scholar from Shanghai Shuguang Hospital(SGXZ-201904) (SGXZ-201904)
the Youth Tip-top Talent Program from Shanghai Municipal Commission of Health,the Constant-eminent Program from Shanghai Municipal Commission of Health,the Xinglin Youth Scholar from Shanghai University of Traditional Chinese Medicine ()
the Norman Bethune Program of Jilin University,China(2022B40). (2022B40)